14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

$0.0680 (4.78%)

Volume: 909.884k

Closed: May 20, 2022

Hollow Logo Score: -3.050

Advaxis Stock Forecast

BUY SELL NASDAQ:ADXS
$0.0680 (4.78%)

Volume: 909.884k

Closed: May 20, 2022

Score Hollow Logo -3.050

Advaxis Stock Price (Quote) NASDAQ:ADXS

$0.0680 ( 4.78% ) Friday, 20th May 2022

Range Low Price High Price Comment
30 days $0.0550 $0.10 Friday, 20th May 2022 ADXS stock ended at $0.0680. This is 4.78% more than the trading day before Thursday, 19th May 2022. During the day the stock fluctuated 24.92% from a day low at $0.0600 to a day high of $0.0750.
90 days $0.0550 $0.14
52 weeks $0.0550 $0.71

Historical Advaxis prices

Date Open High Low Close Volume
2022-05-20 $0.0600 $0.0750 $0.0600 $0.0680 909 884
2022-05-19 $0.0655 $0.0670 $0.0581 $0.0649 472 892
2022-05-18 $0.0680 $0.0749 $0.0652 $0.0749 353 719
2022-05-17 $0.0605 $0.0700 $0.0605 $0.0680 858 146
2022-05-16 $0.0640 $0.0700 $0.0610 $0.0666 244 701
2022-05-13 $0.0700 $0.0700 $0.0580 $0.0640 435 901
2022-05-12 $0.0600 $0.0700 $0.0550 $0.0700 369 710
2022-05-11 $0.0670 $0.0694 $0.0600 $0.0650 366 961
2022-05-10 $0.0699 $0.0699 $0.0699 $0.0699 0
2022-05-09 $0.0760 $0.0825 $0.0633 $0.0699 604 189
2022-05-06 $0.0800 $0.0900 $0.0796 $0.0815 157 379
2022-05-05 $0.0900 $0.0900 $0.0814 $0.0830 387 536
2022-05-04 $0.0901 $0.0901 $0.0801 $0.0900 236 722
2022-05-03 $0.0800 $0.0900 $0.0800 $0.0804 1 573 361
2022-05-02 $0.0785 $0.0900 $0.0720 $0.0890 790 952
2022-04-29 $0.0810 $0.0873 $0.0785 $0.0840 82 370
2022-04-28 $0.0820 $0.0850 $0.0781 $0.0810 183 287
2022-04-27 $0.0880 $0.0880 $0.0781 $0.0820 215 783
2022-04-26 $0.0850 $0.10 $0.0811 $0.0880 642 752
2022-04-25 $0.0853 $0.10 $0.0780 $0.0900 693 458
2022-04-22 $0.0850 $0.0900 $0.0780 $0.0830 234 800
2022-04-21 $0.0900 $0.0900 $0.0800 $0.0850 239 300
2022-04-20 $0.0900 $0.0900 $0.0810 $0.0880 588 400
2022-04-19 $0.0870 $0.0900 $0.0750 $0.0900 437 600
2022-04-18 $0.0870 $0.0900 $0.0750 $0.0790 746 000
2022-04-14 $0.0920 $0.0950 $0.0828 $0.0885 257 209
2022-04-13 $0.11 $0.11 $0.0900 $0.0920 465 269
2022-04-12 $0.0900 $0.11 $0.0850 $0.0998 298 552
2022-04-11 $0.0983 $0.11 $0.0900 $0.0940 154 275
2022-04-08 $0.10 $0.12 $0.10 $0.10 244 000
2022-04-07 $0.11 $0.12 $0.10 $0.10 125 400
2022-04-06 $0.11 $0.12 $0.10 $0.11 373 000
2022-04-05 $0.11 $0.11 $0.0900 $0.11 309 200
2022-04-04 $0.11 $0.13 $0.11 $0.11 311 200
2022-04-01 $0.12 $0.12 $0.11 $0.12 193 573
2022-03-31 $0.12 $0.12 $0.11 $0.12 608 738
2022-03-30 $0.12 $0.13 $0.12 $0.12 137 040
2022-03-29 $0.12 $0.13 $0.11 $0.12 149 200
2022-03-28 $0.12 $0.13 $0.12 $0.12 434 500
2022-03-25 $0.13 $0.13 $0.12 $0.12 352 000
2022-03-24 $0.12 $0.13 $0.12 $0.12 234 600
2022-03-23 $0.12 $0.13 $0.11 $0.12 358 000
2022-03-22 $0.13 $0.13 $0.12 $0.12 196 142
2022-03-21 $0.12 $0.13 $0.12 $0.13 260 710
2022-03-18 $0.12 $0.14 $0.12 $0.13 283 416
2022-03-17 $0.12 $0.14 $0.12 $0.13 490 700
2022-03-16 $0.12 $0.13 $0.11 $0.12 383 000
2022-03-15 $0.14 $0.14 $0.11 $0.12 308 700
2022-03-14 $0.11 $0.14 $0.11 $0.12 2 082 400
2022-03-11 $0.12 $0.12 $0.10 $0.12 329 500

About Advaxis

Advaxis Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. Its lead product Axalimogene filolisbac (ADXS-HPV), an Lm-LLO immunotherapy product candidate, which completed its Phase II study used for the treatment of human papilloma virus (HPV) associated cancers, including cervical, head and neck, and anal cancer. The company is also dev... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT